Cardiovascular Autonomic Dysfunction Before and After Chemotherapy in Cancer Patients

키워드

참고문헌 (92)

1. Jang A, "Heart rate variability as a non-invasive objective parameter for predicting the occurrence of chemotherapy-induced peripheral neuropathy in patients with gastrointestinal cancer", Anticancer Res, 41, pp.2637~2645 (2021)
2. Fadul N, "The association between autonomic dysfunction and survival in male patients with advanced cancer : a preliminary report", J Pain Symptom Manage, 39, pp.283~290 (2010)
3. Teng AE, "Chemotherapy and radiationassociated cardiac autonomic dysfunction", Curr Oncol Rep, 23, pp.14~ (2021)
4. Perrino C, "Cardiac side effects of chemotherapy : state of art and strategies for a correct management", Curr Vasc Pharmacol, 12, pp.106~116 (2014)
5. Yeh ET, "Cardiovascular complications of cancer therapy : incidence, pathogenesis, diagnosis, and management", J Am Coll Cardiol, 53, pp.2231~2247 (2009)
6. Fabiani I, "Subclinical cardiac damage in cancer patients before chemotherapy", Heart Fail Rev, 27, pp.1091~1104 (2022)
7. Spallone V, "Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes : what is defined, what is new, and what is unmet", Diabetes Metab J, 43, pp.3~30 (2019)
8. Lai YR, "Severity of cardiovascular autonomic neuropathy is a predictor associated with major adverse cardiovascular events in adults with type 2diabetes mellitus : a 6-year follow-up study", Can J Diabetes, 45, pp.155~161 (2021)
9. Stone CA, "Autonomic dysfunction in patients with advanced cancer; prevalence, clinical correlates and challenges in assessment", BMC Palliat Care, 11, pp.3~ (2012)
10. Ewing DJ, "Cardiac autonomic neuropathy in diabetes : comparison of measures of R-R interval variation", Diabetologia, 21, pp.18~24 (1981)
11. Guo Y, "Heart rate variability as a measure of autonomic dysfunction in men with advanced cancer", Eur J Cancer Care(Engl), 22, pp.612~616 (2013)
12. Dermitzakis EV, "The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer", BMC Neurol, 16, pp.190~ (2016)
13. Ekholm EM, "Impairment of heart rate variability during paclitaxel therapy", Cancer, 88, pp.2149~2153 (2000)
14. Ekholm E, "Docetaxel and autonomic cardiovascular control in anthracycline treated breast cancer patients", Anticancer Res, 20, pp.2045~2048 (2000)
15. Tjeerdsma G, "Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function : autonomic versus echocardiographic variables", Heart, 81, pp.419~423 (1999)
16. Caru M, "Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors", Clin Res Cardiol, 108, pp.1000~1008 (2019)
17. Meinardi MT, "Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients", J Clin Oncol, 19, pp.2746~2753 (2001)
18. Nuver J, "Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer", J Clin Oncol, 23, pp.9130~9137 (2005)
19. Boogerd W, "Cisplatin induced neuropathy : central, peripheral and autonomic nerve involvement", J Neurooncol, 9, pp.255~263 (1990)
20. Hansen SW, "Autonomic neuropathy after treatment with cisplatin, vinblastine, and bleomycin for germ cell cancer", BMJ, 300, pp.511~512 (1990)
21. Dermitzakis EV, "The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system", Eur J Neurol, 21, pp.1471~1477 (2014)
22. Quasthoff S, "Chemotherapy-induced peripheral neuropathy", J Neurol, 249, pp.9~17 (2002)
23. Nazir HF, "Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman : Frequent autonomic and more severe cranial nerve involvement", Pediatr Blood Cancer, 64, pp.e26677~ (2017)
24. Roca E, "Vinca alkaloid-induced cardiovascular autonomic neuropathy", Cancer Treat Rep, 69, pp.149~151 (1985)
25. Hirvonen HE, "Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy", Cancer, 64, pp.801~805 (1989)
26. Park SB, "Chemotherapy-induced peripheral neurotoxicity : a critical analysis", CA Cancer J Clin, 63, pp.419~437 (2013)
27. Giannoccaro MP, "Somatic and autonomic small fiber neuropathy induced by bortezomib therapy : an immunofluorescence study", Neurol Sci, 32, pp.361~363 (2011)
28. Stratogianni A, "Bortezomib-induced severe autonomic neuropathy", Clin Auton Res, 22, pp.199~202 (2012)
29. Gu Y, "Immune mediated neuropathy following checkpoint immunotherapy", J Clin Neurosci, 45, pp.14~17 (2017)
30. Coumbe BGT, "Cardiovascular autonomic dysfunction in patients with cancer", Curr Cardiol Rep, 20, pp.69~ (2018)
31. Mantovani A, "Cancer-related inflammation", Nature, 454, pp.436~444 (2008)
32. Zhang S, "Interplay between inflammatory tumor microenvironment and cancer stem cells", Oncol Lett, 16, pp.679~686 (2018)
33. Ridker PM, "Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis : exploratory results from a randomised, double-blind, placebo-controlled trial", Lancet, 390, pp.1833~1842 (2017)
34. Aimo A, "Oxidative stress and inflammation in the evolution of heart failure : from pathophysiology to therapeutic strategies", Eur J Prev Cardiol, 27, pp.494~510 (2020)
35. Bertero E, "Linking heart failure to cancer : background evidence and research perspectives", Circulation, 138, pp.735~742 (2018)
36. de Boer RA, "Cancer and heart disease : associations and relations", Eur J Heart Fail, 21, pp.1515~1525 (2019)
37. Tsutsui H, "Oxidative stress and heart failure", Am J Physiol Heart Circ Physiol, 301, pp.H2181~H2190 (2011)
38. Ager EI, "The renin-angiotensin system and malignancy", Carcinogenesis, 29, pp.1675~1684 (2008)
39. Hanif K, "Reinventing the ACE inhibitors : some old and new implications of ACE inhibition", Hypertens Res, 33, pp.11~21 (2010)
40. Deshayes F, "Angiotensin receptors : a new role in cancer?", Trends Endocrinol Metab, 16, pp.293~299 (2005)
41. Siegel RL, "Cancer statistics, 2021", CA Cancer J Clin, 71, pp.7~33 (2021)
42. "SEER Cancer Statistics Review, 1975-2015"[URL]
43. Zajączkowska R, "Mechanisms of chemotherapy-induced peripheral neuropathy", Int J Mol Sci, 20, pp.1451~ (2019)
44. Low VA, "Detection of small-fiber neuropathy by sudomotor testing", Muscle Nerve, 34, pp.57~61 (2006)
45. Hoitsma E, "Small fiber neuropathy : a common and important clinical disorder", J Neurol Sci, 227, pp.119~130 (2004)
46. LaPointe NE, "Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding : implications for chemotherapy-induced peripheral neuropathy", Neurotoxicology, 37, pp.231~239 (2013)
47. Carozzi VA, "Chemotherapy-induced peripheral neuropathy : what do we know about mechanisms?", Neurosci Lett, 596, pp.90~107 (2015)
48. Wani TH, "The dihydroxy metabolite of the teratogen thalidomide causes oxidative DNA damage", Chem Res Toxicol, 30, pp.1622~1628 (2017)
49. Marstrand SD, "Vibration perception threshold and heart rate variability as methods to assess chemotherapy-induced neuropathy in women with breast cancer-a pilot study", Cancer Treat Res Commun, 28, pp.100426~ (2021)
50. Marstrand SD, "Heart rate variability and vibration perception threshold to assess chemotherapy-induced neuropathy in women with breast cancer-a systematic review", Cancer Treat Res Commun, 26, pp.100295~ (2021)
51. Sharabi Y, "Baroreflex failure as a late sequela of neck irradiation", Hypertension, 42, pp.110~116 (2003)
52. Kong L, "Radiation-induced cranial nerve palsy : a cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy", Int J Radiat Oncol Biol Phys, 79, pp.1421~1427 (2011)
53. Goodman BP, "Radiation-induced cranial neuropathies manifesting as baroreflex failure and progressive bulbar impairment", Neurologist, 15, pp.102~104 (2009)
54. Groarke JD, "Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation : evidence of cardiac autonomic dysfunction and impact on outcomes", J Am Coll Cardiol, 65, pp.573~583 (2015)
55. Geraldes V, "Cardiovascular dysautonomia in patients with breast cancer", Open Cardiovasc Med J, 16, pp.e187419242206271~ (2022)
56. Kadish R, "Epidemiology of paraneoplastic neurologic syndromes", Handb Clin Neurol, 200, pp.57~77 (2024)
57. Graus F, "Updated diagnostic criteria for paraneoplastic neurologic syndromes", Neurol Neuroimmunol Neuroinflamm, 8, pp.e1014~ (2021)
58. Lipka AF, "Lambert-Eaton myasthenic syndrome", Handb Clin Neurol, 200, pp.307~325 (2024)
59. Sun X, "Anti-SOX1 antibodies in paraneoplastic neurological syndrome", J Clin Neurol, 16, pp.530~546 (2020)
60. Liguori R, "Morvan’s syndrome : peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels", Brain, 124, pp.2417~2426 (2001)
61. Swayang PS, "CASPR2-related morvan syndrome : autonomic, polysomnographic, and neuropsychological observations", Neurol Clin Pract, 11, pp.e267~e276 (2021)
62. Josephs KA, "Neurophysiologic studies in Morvan syndrome", J Clin Neurophysiol, 21, pp.440~445 (2004)
63. Golden EP, "Autoimmune autonomic neuropathies and ganglionopathies : epidemiology, pathophysiology, and therapeutic advances", Clin Auton Res, 29, pp.277~288 (2019)
64. Golden EP, "Paraneoplastic autonomic neuropathies and GI dysmotility", Handb Clin Neurol, 200, pp.275~282 (2024)
65. Villagrán-García M, "Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes", Rev Neurol(Paris), 180, pp.107~116 (2024)
66. Villagrán-García M, "Dysautonomia in anti-Hu paraneoplastic neurological syndromes", J Neurol, 271, pp.3359~3369 (2024)
67. Graus F, "Clinical approach to diagnosis of paraneoplastic neurologic syndromes", Handb Clin Neurol, 200, pp.79~96 (2024)
68. Kerstens J, "Overview of treatment strategies in paraneoplastic neurological syndromes", Handb Clin Neurol, 200, pp.97~112 (2024)
69. Cheshire WP Jr, "The physical examination as a window into autonomic disorders", Clin Auton Res, 28, pp.23~33 (2018)
70. Khurana RK, "Coat-hanger ache in orthostatic hypotension", Cephalalgia, 32, pp.731~737 (2012)
71. Low PA, "Autonomic function tests : some clinical applications", J Clin Neurol, 9, pp.1~8 (2013)
72. Quispe RC, "Auxiliary tests of autonomic functions", J Clin Neurophysiol, 38, pp.262~273 (2021)
73. Cheshire WP, "Electrodiagnostic assessment of the autonomic nervous system : a consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology", Clin Neurophysiol, 132, pp.666~682 (2021)
74. Cheshire WP Jr, "Autonomic uprising : the tilt table test in autonomic medicine", Clin Auton Res, 29, pp.215~230 (2019)
75. Goh JK, "Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus : a systematic review", Diabetol Int, 14, pp.224~242 (2023)
76. Hamasaki H, "The effect of exercise on cardiovascular autonomic nervous function in patients with diabetes : a systematic review", Healthcare(Basel), 11, pp.2668~ (2023)
77. Vágvölgyi A, "A three-month physical training program improves cardiovascular autonomic function in patients with metabolic syndrome with and without diabetes-a pilot study", Front Endocrinol(Lausanne), 14, pp.1224353~ (2023)
78. Adams SC, "Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors : a phase 2randomized controlled trial", Cancer, 123, pp.4057~4065 (2017)
79. Kirkham AA, "A longitudinal study of the association of clinical indices of cardiovascular autonomic function with breast cancer treatment and exercise training", Oncologist, 24, pp.273~284 (2019)
80. Lavín-Pérez AM, "Can exercise reduce the autonomic dysfunction of patients with cancer and its survivors? A systematic review and metaanalysis", Front Psychol, 12, pp.712823~ (2021)
81. Goldstein DS, "Stress and the autonomic nervous system", Auton Neurosci, 247, pp.103096~ (2023)
82. De Couck M, "The role of the vagus nerve in cancer prognosis : a systematic and a comprehensive review", J Oncol, 2018, pp.1236787~ (2018)
83. Inbaraj G, "Effects of an 18-week integrated yoga program on cardiac autonomic function in breast cancer patients undergoing adjuvant chemotherapy : a randomized controlled trial", Integr Cancer Ther, 22, pp.15347354231168795~ (2023)
84. Tai HY, "Efficacy of cryotherapy in the prevention of chemotherapy-induced peripheral neuropathy : a systematic review and meta-analysis", Support Care Cancer, 32, pp.482~ (2024)
85. Ng DQ, "Impact of cryotherapy on sensory, motor, and autonomic neuropathy in breast cancer patients receiving paclitaxel : a randomized, controlled trial", Front Neurol, 11, pp.604688~ (2020)
86. Wieling W, "Diagnosis and treatment of orthostatic hypotension", Lancet Neurol, 21, pp.735~746 (2022)
87. Cardinale D, "Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition", Circulation, 114, pp.2474~2481 (2006)
88. Cadeddu C, "Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment", Am Heart J, 160, pp.487~ (2010)
89. Smith W, "Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension : a phase 4, double-blind, placebo-controlled, randomized, tilt-table study", Clin Auton Res, 26, pp.269~277 (2016)
90. Biaggioni I, "Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension", BMC Neurol, 17, pp.90~ (2017)
91. Park JW, "Pharmacologic treatment of orthostatic hypotension", Auton Neurosci, 229, pp.102721~ (2020)
92. Rao SV, "Erythropoietin, anemia, and orthostatic hypotension : the evidence mounts", Clin Auton Res, 12, pp.141~143 (2002)

관련 논문AI추천